Literature DB >> 15937734

Evaluation and treatment of painful peripheral polyneuropathy.

J Robinson Singleton1.   

Abstract

Pain is a common component of sensory peripheral polyneuropathy and occurs primarily as a consequence of injury to small, unmyelinated C-fiber nerve axons. This class of fibers is particularly vulnerable to metabolic injury, and the neuropathy manifests in a length-dependent pattern. Diabetes mellitus, prediabetes associated with insulin resistance, toxins, and drugs are common causes of painful neuropathy, but a substantial percentage are idiopathic. Pathogenesis of neuropathic pain involves loss of peripheral axons and inappropriate peripheral and central adaptation of neuronal signaling to this loss. Treatment of painful neuropathy should be directed at removing the offending metabolic injury, if possible. Antiepileptic drugs, tricyclic antidepressants, opiates, and other treatments have shown efficacy in clinical trials for symptomatic relief of neuropathic pain.

Entities:  

Mesh:

Year:  2005        PMID: 15937734     DOI: 10.1055/s-2005-871327

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  7 in total

1.  Chiropractic management of a 24-year-old woman with idiopathic, intermittent right-sided hemiparesthesia.

Authors:  Joseph Bova; Adam Sergent
Journal:  J Chiropr Med       Date:  2014-12

2.  Neuropathic pain in patients with Charcot-Marie-Tooth type 1A.

Authors:  Bogdan Bjelica; Stojan Peric; Ivana Basta; Ivo Bozovic; Aleksandra Kacar; Ana Marjanovic; Vukan Ivanovic; Marija Brankovic; Milena Jankovic; Ivana Novakovic; Vidosava Rakocevic Stojanovic
Journal:  Neurol Sci       Date:  2019-11-15       Impact factor: 3.307

Review 3.  Neuropathy in Human Immunodeficiency Virus: A Review of the Underlying Pathogenesis and Treatment.

Authors:  Lakshya Motwani; Nailah Asif; Apurva Patel; Deepanjali Vedantam; Devyani S Poman
Journal:  Cureus       Date:  2022-06-13

4.  Dose escalating safety study of CNS 5161 HCl, a new neuronal glutamate receptor antagonist (NMDA) for the treatment of neuropathic pain.

Authors:  Thomas Forst; Terry Smith; Klemens Schütte; Paul Marcus; Andreas Pfützner
Journal:  Br J Clin Pharmacol       Date:  2007-03-28       Impact factor: 4.335

5.  Evidence for a novel subcortical mechanism for posterior cingulate cortex atrophy in HIV peripheral neuropathy.

Authors:  John R Keltner; Alan Tong; Eelke Visser; Mark Jenkinson; Colm G Connolly; Alyssa Dasca; Aleks Sheringov; Zachary Calvo; Earl Umbao; Rohit Mande; Mary Beth Bilder; Gagandeep Sahota; Donald R Franklin; Stephanie Corkran; Igor Grant; Sarah Archibald; Florin Vaida; Gregory G Brown; J Hampton Atkinson; Alan N Simmons; Ronald J Ellis
Journal:  J Neurovirol       Date:  2020-06-10       Impact factor: 3.739

6.  Hypoxia-induced sensitisation of TRPA1 in painful dysesthesia evoked by transient hindlimb ischemia/reperfusion in mice.

Authors:  Kanako So; Yuna Tei; Meng Zhao; Takahito Miyake; Haruka Hiyama; Hisashi Shirakawa; Satoshi Imai; Yasuo Mori; Takayuki Nakagawa; Kazuo Matsubara; Shuji Kaneko
Journal:  Sci Rep       Date:  2016-03-17       Impact factor: 4.379

Review 7.  Decompressive surgery of lower limbs for symmetrical diabetic peripheral neuropathy.

Authors:  Vinay Chaudhry; James Russell; Allan Belzberg
Journal:  Cochrane Database Syst Rev       Date:  2008-07-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.